GSA Capital Partners’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-204,524
Closed -$315K 1984
2021
Q4
$315K Sell
204,524
-214,281
-51% -$354K 0.04% 896
2021
Q3
$658K Buy
+418,805
New +$820K 0.07% 525
2021
Q1
Sell
-126,151
Closed -$164K 1637
2020
Q4
$164K Buy
126,151
+41,757
+49% +$47K 0.03% 1034
2020
Q3
$95K Buy
84,394
+59,235
+235% +$65.1K 0.02% 1140
2020
Q2
$21K Buy
+25,159
New +$18.7K 0.01% 558
2020
Q1
Sell
-40,565
Closed -$54K 1720
2019
Q4
$54K Buy
+40,565
New +$56.6K 0.01% 1368

GSA Capital Partners's CSLT Position: Q1 2022 in Review

GSA Capital Partners sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 204,524 shares — an estimated $315K sold.

GSA Capital Partners first reported a position in CSLT in Q4 2019 and held it in 6 quarters. The position peaked at $658K in Q3 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • GSA Capital Partners reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • GSA Capital Partners sold 204,524 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $315K.
  • GSA Capital Partners first reported a position in CASTLIGHT HEALTH, INC. in Q4 2019 and held it in 6 quarters.
  • GSA Capital Partners's CASTLIGHT HEALTH, INC. position peaked at $658K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.